Arctigenin Suppresses Unfolded Protein Response and Sensitizes Glucose Deprivation-Mediated Cytotoxicity of Cancer Cells

Abstract

The involvement of unfolded protein response (UPR) activation in tumor survival and resistance to chemotherapies suggests a new anticancer strategy targeting UPR pathway. Arctigenin, a natural product, has been recently identified for its antitumor activity with selective toxicity against cancer cells under glucose starvation with unknown mechanism. Here we found that arctigenin specifically blocks the transcriptional induction of two potential anticancer targets, namely glucose-regulated protein-78 (GRP78) and its analog GRP94, under glucose deprivation, but not by tunicamycin. The activation of other UPR pathways, e.g., XBP-1 and ATF4, by glucose deprivation was also suppressed by arctigenin. A further transgene experiment showed that ectopic expression of GRP78 at least partially rescued arctigenin/glucose starvation-mediated cell growth inhibition, suggesting the causal role of UPR suppression in arctigenin-mediated cytotoxicity under glucose starvation. These observations bring a new insight into the mechanism of action of arctigenin and may lead to the design of new anticancer therapeutics.

Key words

arctigenin - unfolded protein response (UPR) - GRP78 - glucose deprivation - cytotoxicity - cancer - 2DG

References

• 1 Garber K. Energy deregulation: licensing tumors to grow.  Science. 2006;  312 1158-1159
• 2 Reddy R K, Lu J, Lee A S. The endoplasmic reticulum chaperone glycoprotein GRP94 with Ca(2+)-binding and antiapoptotic properties is a novel proteolytic target of calpain during etoposide-induced apoptosis.  J Biol Chem. 1999;  274 28476-28483
• 3 Reddy R K, Mao C, Baumeister P, Austin R C, Kaufman R J, Lee A S. Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation.  J Biol Chem. 2003;  278 20915-20924
• 4 Elstrom R L, Bauer D E, Buzzai M, Karnauskas R, Harris M H, Plas D R, Zhuang H, Cinalli R M, Alavi A, Rudin C M, Thompson C B. Akt stimulates aerobic glycolysis in cancer cells.  Cancer Res. 2004;  64 3892-3899
• 5 Robey R B, Hay N. Akt, hexokinase, mTOR: targeting cellular energy metabolism for cancer therapy.  Drug Discov Today Dis Mech. 2005;  2 239-246
• 6 Park H R, Tomida A, Sato S, Tsukumo Y, Yun J, Yamori T, Hayakawa Y, Tsuruo T, Shin-ya K. Effect on tumor cells of blocking survival response to glucose deprivation.  J Natl Cancer Inst. 2004;  96 1300-1310
• 7 Arap M A, Lahdenranta J, Mintz P J, Hajitou A, Sarkis A S, Arap W, Pasqualini R. Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands.  Cancer Cell. 2004;  6 275-284
• 8 Li Q X, Yu D H, Liu G, Ke N, McKelvy J, Wong-Staal F. Selective anticancer strategies via intervention of the death pathways relevant to cell transformation.  Cell Death Differ. 2008;  15 1197-1210
• 9 Takasaki M, Konoshima T, Komatsu K, Tokuda H, Nishino H. Anti-tumor-promoting activity of lignans from the aerial part of Saussurea medusa.  Cancer Lett. 2000;  158 53-59
• 10 Awale S, Lu J, Kalauni S K, Kurashima Y, Tezuka Y, Kadota S, Esumi H. Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation.  Cancer Res. 2006;  66 1751-1757
• 11 Yu D H, Macdonald J, Liu G, Lee A S, Ly M, Davis T, Ke N, Zhou D, Wong-Staal F, Li Q X. Pyrvinium targets the unfolded protein response to hypoglycemia and its anti-tumor activity is enhanced by combination therapy.  PLoS One. 2008;  3 e3951
• 12 Yu D H, Chatterton J E, Bliesath J R, Sundaram R, Ke N, Nguy V, Meyhack B, Wong-Staal F, Li Q X. A 96-well surrogate survival assay coupled with a special short interfering RNA vector for assessing cancer gene targets with enhanced signal/noise ratio and its utility in HTS for cancer therapeutic targets.  Assay Drug Dev Technol. 2005;  3 401-411
• 13 Yu D H, Fan W, Liu G, Nguy V, Chatterton J E, Long S, Ke N, Meyhack B, Bruengger A, Brachat A, Wong-Staal F, Li Q X. PHTS, a novel putative tumor suppressor, is involved in the transformation reversion of HeLaHF cells independently of the p53 pathway.  Exp Cell Res. 2006;  312 865-876
• 14 Fu Y, Lee A S. Glucose regulated proteins in cancer progression, drug resistance and immunotherapy.  Cancer Biol Ther. 2006;  5 741-744
• 15 Bernales S, Papa F R, Walter P. Intracellular signaling by the unfolded protein response.  Annu Rev Cell Dev Biol. 2006;  22 487-508
• 16 Luo S, Baumeister P, Yang S, Abcouwer S F, Lee A S. Induction of Grp78/BiP by translational block: activation of the Grp78 promoter by ATF4 through and upstream ATF/CRE site independent of the endoplasmic reticulum stress elements.  J Biol Chem. 2003;  278 37375-37385
• 17 Harding H P, Zhang Y, Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase.  Nature. 1999;  397 271-274
• 18 Shi Y, Vattem K M, Sood R, An J, Liang J, Stramm L, Wek R C. Identification and characterization of pancreatic eukaryotic initiation factor 2 alpha-subunit kinase, PEK, involved in translational control.  Mol Cell Biol. 1998;  18 7499-7509
• 19 Romero-Ramirez L, Cao H, Nelson D, Hammond E, Lee A H, Yoshida H, Mori K, Glimcher L H, Denko N C, Giaccia A J, Le Q T, Koong A C. XBP1 is essential for survival under hypoxic conditions and is required for tumor growth.  Cancer Res. 2004;  64 5943-5947
• 20 Esumi H, Lu J, Kurashima Y, Hanaoka T. Antitumor activity of pyrvinium pamoate, 6-(dimethylamino)-2-[2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl]-1-methyl-quinolinium pamoate salt, showing preferential cytotoxicity during glucose starvation.  Cancer Sci. 2004;  95 685-690
• 21 Ermakova S P, Kang B S, Choi B Y, Choi H S, Schuster T F, Ma W Y, Bode A M, Dong Z. (−)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78.  Cancer Res. 2006;  66 9260-9269
• 22 Ishihara K, Yamagishi N, Saito Y, Takasaki M, Konoshima T, Hatayama T. Arctigenin from Fructus Arctii is a novel suppressor of heat shock response in mammalian cells.  Cell Stress Chaperones. 2006;  11 154-161
• 23 Patterson J, Palombella V J, Fritz C, Normant E. IPI-504, a novel and soluble HSP-90 inhibitor, blocks the unfolded protein response in multiple myeloma cells.  Cancer Chemother Pharmacol. 2008;  61 923-932
• 24 Maschek G, Savaraj N, Priebe W, Braunschweiger P, Hamilton K, Tidmarsh G F, De Young L R, Lampidis T J. 2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo.  Cancer Res. 2004;  64 31-34